0001209191-20-052459.txt : 20200930
0001209191-20-052459.hdr.sgml : 20200930
20200930163704
ACCESSION NUMBER: 0001209191-20-052459
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200928
FILED AS OF DATE: 20200930
DATE AS OF CHANGE: 20200930
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Manning Paul B
CENTRAL INDEX KEY: 0001494695
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39536
FILM NUMBER: 201212646
MAIL ADDRESS:
STREET 1: 200 GARRETT STREET SUITE S
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Taysha Gene Therapies, Inc.
CENTRAL INDEX KEY: 0001806310
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 843199512
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7318 MORTON STREET
CITY: DALLAS
STATE: TX
ZIP: 75209
BUSINESS PHONE: 212.551.8702
MAIL ADDRESS:
STREET 1: 7318 MORTON STREET
CITY: DALLAS
STATE: TX
ZIP: 75209
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-28
0
0001806310
Taysha Gene Therapies, Inc.
TSHA
0001494695
Manning Paul B
C/O TAYSHA GENE THERAPIES, INC.
2280 INWOOD ROAD
DALLAS
TX
75235
1
0
1
0
Common Stock
2020-09-28
4
C
0
3275205
A
3275205
I
See Footnote
Common Stock
2020-09-28
4
C
0
2008158
A
2008158
I
See Footnote
Common Stock
2020-09-28
4
C
0
11944
A
2020102
I
See Footnote
Series A Preferred Stock
2020-09-28
4
C
0
3006155
0.00
D
Common Stock
3275205
0
I
See Footnote
Series A Preferred Stock
2020-09-28
4
C
0
1843193
0.00
D
Common Stock
2008158
0
I
See Footnote
Series B Preferred Stock
2020-09-28
4
C
0
10963
0.00
D
Common Stock
11944
0
I
See Footnote
Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a one for-1.0895 basis, and had no expiration date.
The securities are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the
Trust and has sole voting and investment power with respect to the shares held by the Trust.
The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB.
/s/ Kamran Alam, Attorney-in-Fact
2020-09-30